Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Sang Shin
Affiliation
Feinberg School of Medicine, Northwestern University
ORCID
Career Start Year
2009
Papers
9
H Index
7
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36915208
Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.
Genome Med
2023
31238177
Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer.
J Thorac Oncol
2019
29349597
Drug repurposing screening identifies bortezomib and panobinostat as drugs targeting cancer associated fibroblasts (CAFs) by synergistic induction of apoptosis.
Invest New Drugs
2018
30262818
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.
Nat Genet
2018
28806950
Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification.
BMC Cancer
2017
28263318
Spatiotemporal genomic architecture informs precision oncology in glioblastoma.
Nat Genet
2017
27139883
Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma.
Genome Biol
2016
25549722
Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
Clin Cancer Res
2015
19169686
Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study.
Cancer Chemother Pharmacol
2009
1 - 9 of 9
Column Actions
Search
Recommended Authors
Xue Wu
Nanjing Geneseeq Technology Inc.
Career Start Year
2016
Number of shared co-authors
0
Raunak Shrestha
University of California San Francisco
Career Start Year
2014
Number of shared co-authors
0
Sahil Seth
The University of Texas MD Anderson Cancer Center
Career Start Year
2014
Number of shared co-authors
4
Yang Shao
Nanjing Geneseeq Technology Inc.
Career Start Year
2012
Number of shared co-authors
0
Yisong Wang
Lombardi Comprehensive Cancer Center, Georgetown University
Career Start Year
2010
Number of shared co-authors
0
Marzia Del Re
University of Pisa
Career Start Year
2010
Number of shared co-authors
0
Vibha Raghavan
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2009
Number of shared co-authors
0
Maxim Sidorov
California Pacific Medical Center Research Institute
Career Start Year
2009
Number of shared co-authors
0
Bo Gao
Crown Princess Mary Cancer Centre, Westmead Hospital
Career Start Year
2008
Number of shared co-authors
0
John Paul Shen
The University of Texas MD Anderson Cancer Center
Career Start Year
2006
Number of shared co-authors
2
Rodrigo Dienstmann
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus
Career Start Year
2006
Number of shared co-authors
0
Martin L Sos
University of Cologne, Faculty of Medicine and University Hospital Cologne
Career Start Year
2005
Number of shared co-authors
1
Kris C Wood
Duke University
Career Start Year
2005
Number of shared co-authors
0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
1
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year
2003
Number of shared co-authors
1
Jonathan R Dry
Present Address: Tempus Labs Inc.
Career Start Year
2003
Number of shared co-authors
3
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year
2003
Number of shared co-authors
0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year
2003
Number of shared co-authors
0
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year
2003
Number of shared co-authors
0
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year
2002
Number of shared co-authors
2
Trever G Bivona
University of California san francisco
Career Start Year
2002
Number of shared co-authors
3
Simon Kreutzfeldt
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year
2002
Number of shared co-authors
0
Nikhil Wagle
Dana-Farber Cancer Institute
Career Start Year
2000
Number of shared co-authors
4
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year
1999
Number of shared co-authors
1
Mathew J Garnett
Wellcome Sanger Institute
Career Start Year
1998
Number of shared co-authors
0
Collin M Blakely
University of California san francisco
Career Start Year
1998
Number of shared co-authors
1
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year
1996
Number of shared co-authors
2
Vincent A Miller
Injury Prevention Research Center, University of North Carolina
Career Start Year
1994
Number of shared co-authors
7
Ultan McDermott
Wellcome Sanger Institute
Career Start Year
1993
Number of shared co-authors
1
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year
1974
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers
6
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers
5
Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers
4
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
4
Yong-Jun Kwon
Luxembourg Institute of Health
Co-authored papers
4
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers
4
Seung Won Choi
Samsung Medical Center, Sungkyunkwan University
Co-authored papers
3
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Co-authored papers
3
Doo-Sik Kong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
3
Jiguang Wang
The Hong Kong University of Science and Technology
Co-authored papers
3
Jason K Sa
Korea University, College of Medicine
Co-authored papers
3
Zhaoqi Liu
University of Chinese Academy of Sciences
Co-authored papers
2
Donggeon Kim
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers
2
Byong Chang Jeong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
2
In-Hee Lee
Children's Hospital Boston
Co-authored papers
2
Yeup Yoon
Sungkyunkwan University
Co-authored papers
2
Yong Jae Shin
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers
2
Kyu-Tae Kim
Ajou University
Co-authored papers
2
Jeong-Woo Oh
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers
2
Chul-Kee Park
College of Medicine, Seoul National University
Co-authored papers
2
Hyun Ju Kang
Genomic Medicine Institute, Medical Research Center, Seoul National University
Co-authored papers
2
Jin-Ku Lee
Seoul National University, College of Medicine
Co-authored papers
2
Daniel I S Rosenbloom
Merck & Co. Inc.
Co-authored papers
2
Young Mog Shim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
2
Hae-Ock Lee
College of Medicine, The Catholic University of Korea
Co-authored papers
2
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers
2
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Co-authored papers
2
In-Hee Lee
Co-authored papers
2
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers
2
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
2
1 - 30